Nizza, Washington From January 1988 at the latest, the daily intake of low-dose acetylsalicylic acid (ASA) has been seen as a means to reduce the risk of heart attacks. But while many millions of people have been using the aspirin ingredient since then, its value is being viewed more and more critically by scientists. A new European-American study now speaks of a significantly increased risk of cardiac insufficiency when taking ASA.

For the study, the scientists analyzed the data from 30,827 heart failure patients in Western Europe and the USA. The average age was 67 years. 7698 test subjects took aspirin, that was 25 percent of the patients. The observation period was 5.3 years. 1330 of the patients developed a pumping weakness of the heart.

When evaluating the information, the scientists mathematically compensated for other risks. The result: “The intake of aspirin was correlated with a 26 percent increased risk of heart failure, regardless of other factors.” The results of the observational study were then checked by assigning a control person to each person who had reported using ASA without taking ASA. This analysis also showed a risk increase of 26 percent. Even in 22,690 study participants without a diagnosed cardiovascular disease, a 27 percent increased risk of heart failure was registered when taking ASA. According to German cardiologists, large international studies should now verify these results in order to be able to make final statements. Until then, caution should be exercised when prescribing ASA.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.